Skip to main content

Table 3 Detection rates of the different test systems and rates of invalid test results

From: Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages

 

cobas HPV (all 14 types)

cobas HPV (HPV16/18)

CINtec Plus

GynTect

NILM

7.5%

3.0%

1.8%

1,5%

CIN1

100.0%

60.0%

100.0%

20.0%

CIN2

100.0%

63.2%

100.0%

44.4%

CIN3

96.0%

66.0%

100.0%

61.2%

Cancer

100.0%

80.0%

100.0%

100.0%

invalid test results

0.36%

0.36%

3.62%

1.43%